TP53 and head and neck squamous cell carcinoma: Importantly, Kaplan–Meier analysis showed that PLEKHA1-TACC2 expression combined with TP53 missense mutation in ESCC and HNSCC was remarkably associated with poorer OS (Fig. 5B).